Form 4 for PCVX Vaxcyte, Inc.
Accepted 2024-09-05 00:00:00 ET · period of report 2024-09-03 · accession 0001649094-24-000062 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-09-05 | 2024-09-03 | PCVX | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | S - Sale+OE | $112.11 | -1,667 | 30.9K | -5% | -$186.9K |
| D | 2024-09-05 | 2024-09-03 | PCVX | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | F - Tax | $110.15 | -2,203 | 28.6K | -7% | -$242.7K |
| D | 2024-09-05 | 2024-09-03 | PCVX | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | M - OptEx | $21.41 | +1,667 | 32.5K | +5% | +$35.7K |
| D | 2024-09-05 | 2024-09-03 | PCVX | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | M - OptEx | $0.00 | -1,667 | 180.0K | -0.9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-03 | S | D | 523 | $110.45 | 31,966 | D | — | — | (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $110.12 to $110.76. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2024-09-03 | F | D | 2,203 | $110.15 | 28,623 | D | — | — | (F5) Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of restricted stock units. No other shares of common stock subject to the restrictions on transfer set forth in a Lock-Up Agreement dated September 4, 2024 were sold by the Reporting Person. |
| 3 | Common | Common Stock | 2024-09-03 | M | A | 1,667 | $21.41 | 32,493 | D | — | — | |
| 4 | Common | Common Stock | 2024-09-03 | S | D | 4 | $107.67 | 32,489 | D | — | — | |
| 5 | Common | Common Stock | 2024-09-03 | S | D | 80 | $117.28 | 30,826 | D | — | — | |
| 6 | Common | Common Stock | 2024-09-03 | S | D | 715 | $111.57 | 31,251 | D | — | — | (F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $111.16 to $112.14. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 7 | Common | Common Stock | 2024-09-03 | S | D | 122 | $112.66 | 31,129 | D | — | — | (F4) The price reported is a weighted-average price. The shares were sold at prices ranging from $112.35 to $113.14. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 8 | Common | Common Stock | 2024-09-03 | S | D | 79 | $114.96 | 31,050 | D | — | — | |
| 9 | Common | Common Stock | 2024-09-03 | S | D | 144 | $116.01 | 30,906 | D | — | — | |
| 10 | Derivative | Stock Option (right to buy) | 2024-09-03 | M | D | 1,667 | $0.00 | 179,997 | D | $21.41 · — to 2032-05-08 | 1,667 Common Stock | (F6) 1/4 of the shares subject to the option vested on April 1, 2023, and 1/48 of the shares shall vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date. |